Adding genetic testing to the evaluation of pediatric patients with neurodevelopmental disorders (NDD) resulted in more individualized care, including changes in medication, referrals to clinical ...

In a new study, UCLA Health researchers have found that motor delay and low muscle tone were common signs of an underlying genetic diagnosis in children with neurodevelopment disorders. Given the ...

– The Alnylam Act ® program is a genetic testing initiative designed to enable improved patient diagnosis of three rare, devastating, and life-threatening genetic diseases – – Through the Alnylam Act ...

Rare genetic disorders affect more than 300 million people worldwide, with children making up 70% of those impacted, according to EURORDIS. These conditions often go undiagnosed for years due to ...

Including genetic testing in evaluations for children with autism, developmental delay and other neurodevelopmental disorders often leads to major changes in care, researchers say. In a study looking ...

In 2025, Baylor Genetics was named an official genetic testing partner of the Child Neurology Society.

BOSTON--(BUSINESS WIRE)--Variantyx, a leader in high complexity hereditary disease testing, today announced that they secured $20M in funding for their Whole Genome Sequencing (WGS)-based testing ...

Pregnancy is a beautiful journey, but it can come with a lot of questions, especially about tests like genetic testing. So, what is it exactly? It’s a way to check your baby’s DNA to see if there are ...